Concise Drug Review: Azacitidine and Decitabine

Name: Work Video:
Duration: 3 min 30 s
Description: The introduction of the hypomethylating agents azacitidine and decitabine has been a major advancement in the treatment of patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia who are ineligible for more intensive treatments. This concise drug review summarizes the current state of treatment with azacitidine and decitabine.
Ellen J. B. Derissen; Jos H. Beijnen; Jan H.M. Schellens
{'id': 'https://openalex.org/W2127289529', 'doi': 'https://doi.org/10.1634/theoncologist.2012-0465', 'title': 'Concise Drug Review: Azacitidine and Decitabine', 'display_name': 'Concise Drug Review: Azacitidine and Decitabine', 'publication_year': 2013, 'publication_date': '2013-05-01', 'ids': {'openalex': 'https://openalex.org/W2127289529', 'doi': 'https://doi.org/10.1634/theoncologist.2012-0465', 'mag': '2127289529', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/23671007', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/3662854'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2012-0465', 'pdf_url': 'http://theoncologist.alphamedpress.org/content/18/5/619.full.pdf', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'http://theoncologist.alphamedpress.org/content/18/5/619.full.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5067607823', 'display_name': 'Ellen J. B. Derissen', 'orcid': 'https://orcid.org/0000-0001-5865-4291'}, 'institutions': [{'id': 'https://openalex.org/I2802065108', 'display_name': 'Slotervaartziekenhuis', 'ror': 'https://ror.org/01w502745', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802065108']}, {'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Ellen J.B. Derissen', 'raw_affiliation_strings': ['Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands;'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands;', 'institution_ids': ['https://openalex.org/I2802065108', 'https://openalex.org/I2898336195']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062227574', 'display_name': 'Jos H. Beijnen', 'orcid': 'https://orcid.org/0000-0003-0118-561X'}, 'institutions': [{'id': 'https://openalex.org/I2802065108', 'display_name': 'Slotervaartziekenhuis', 'ror': 'https://ror.org/01w502745', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802065108']}, {'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}, {'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Jos H. Beijnen', 'raw_affiliation_strings': ['Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands;', 'cDepartment of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands;', 'institution_ids': ['https://openalex.org/I2802065108', 'https://openalex.org/I2898336195']}, {'raw_affiliation_string': 'cDepartment of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands', 'institution_ids': ['https://openalex.org/I193662353']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5000418012', 'display_name': 'Jan H.M. Schellens', 'orcid': 'https://orcid.org/0000-0001-6832-1976'}, 'institutions': [{'id': 'https://openalex.org/I4210111138', 'display_name': 'Oncode Institute', 'ror': 'https://ror.org/01n92vv28', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I4210111138']}, {'id': 'https://openalex.org/I2898336195', 'display_name': 'The Netherlands Cancer Institute', 'ror': 'https://ror.org/03xqtf034', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2898336195']}, {'id': 'https://openalex.org/I193662353', 'display_name': 'Utrecht University', 'ror': 'https://ror.org/04pp8hn57', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I193662353']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Jan H.M. Schellens', 'raw_affiliation_strings': ['bDepartment of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;', 'cDepartment of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'bDepartment of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;', 'institution_ids': ['https://openalex.org/I4210111138', 'https://openalex.org/I2898336195']}, {'raw_affiliation_string': 'cDepartment of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands', 'institution_ids': ['https://openalex.org/I193662353']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3494, 'currency': 'USD', 'value_usd': 3494, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 8.523, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 248, 'citation_normalized_percentile': {'value': 0.999868, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '18', 'issue': '5', 'first_page': '619', 'last_page': '624'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10309', 'display_name': 'Acute Myeloid Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9956, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10269', 'display_name': 'Epigenetics and DNA Methylation', 'score': 0.99, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/azacitidine', 'display_name': 'Azacitidine', 'score': 0.9857565}, {'id': 'https://openalex.org/keywords/decitabine', 'display_name': 'Decitabine', 'score': 0.9839522}, {'id': 'https://openalex.org/keywords/chronic-myelomonocytic-leukemia', 'display_name': 'Chronic myelomonocytic leukemia', 'score': 0.56931394}], 'concepts': [{'id': 'https://openalex.org/C2776239401', 'wikidata': 'https://www.wikidata.org/wiki/Q416451', 'display_name': 'Azacitidine', 'level': 5, 'score': 0.9857565}, {'id': 'https://openalex.org/C2780235182', 'wikidata': 'https://www.wikidata.org/wiki/Q1181878', 'display_name': 'Decitabine', 'level': 5, 'score': 0.9839522}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.74682426}, {'id': 'https://openalex.org/C2780817109', 'wikidata': 'https://www.wikidata.org/wiki/Q954625', 'display_name': 'Myelodysplastic syndromes', 'level': 3, 'score': 0.72574997}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.7010757}, {'id': 'https://openalex.org/C2777928532', 'wikidata': 'https://www.wikidata.org/wiki/Q1088072', 'display_name': 'Chronic myelomonocytic leukemia', 'level': 4, 'score': 0.56931394}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.41980475}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.34811282}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.31596124}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.26496804}, {'id': 'https://openalex.org/C2780007613', 'wikidata': 'https://www.wikidata.org/wiki/Q546523', 'display_name': 'Bone marrow', 'level': 2, 'score': 0.076421976}, {'id': 'https://openalex.org/C190727270', 'wikidata': 'https://www.wikidata.org/wiki/Q874745', 'display_name': 'DNA methylation', 'level': 4, 'score': 0.074400574}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.064845145}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C150194340', 'wikidata': 'https://www.wikidata.org/wiki/Q26972', 'display_name': 'Gene expression', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D017326', 'descriptor_name': 'Clinical Trials, Phase III as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000964', 'descriptor_name': 'Antimetabolites, Antineoplastic', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000964', 'descriptor_name': 'Antimetabolites, Antineoplastic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001374', 'descriptor_name': 'Azacitidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077209', 'descriptor_name': 'Decitabine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015470', 'descriptor_name': 'Leukemia, Myeloid, Acute', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D015470', 'descriptor_name': 'Leukemia, Myeloid, Acute', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015477', 'descriptor_name': 'Leukemia, Myelomonocytic, Chronic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015477', 'descriptor_name': 'Leukemia, Myelomonocytic, Chronic', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009190', 'descriptor_name': 'Myelodysplastic Syndromes', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2012-0465', 'pdf_url': 'http://theoncologist.alphamedpress.org/content/18/5/619.full.pdf', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc3662854', 'pdf_url': 'https://europepmc.org/articles/pmc3662854?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662854', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23671007', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2012-0465', 'pdf_url': 'http://theoncologist.alphamedpress.org/content/18/5/619.full.pdf', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.81, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 39, 'referenced_works': ['https://openalex.org/W1479954515', 'https://openalex.org/W1511596951', 'https://openalex.org/W1513468396', 'https://openalex.org/W1764888106', 'https://openalex.org/W1893997768', 'https://openalex.org/W1974749085', 'https://openalex.org/W1979806945', 'https://openalex.org/W1988907854', 'https://openalex.org/W1992275797', 'https://openalex.org/W1996185620', 'https://openalex.org/W2015776863', 'https://openalex.org/W2017394727', 'https://openalex.org/W2018440411', 'https://openalex.org/W2028627376', 'https://openalex.org/W2029595590', 'https://openalex.org/W2034160841', 'https://openalex.org/W2046140083', 'https://openalex.org/W2052812042', 'https://openalex.org/W2079671946', 'https://openalex.org/W2080270409', 'https://openalex.org/W2081279521', 'https://openalex.org/W2081895311', 'https://openalex.org/W2086492419', 'https://openalex.org/W2093688161', 'https://openalex.org/W2106082819', 'https://openalex.org/W2106084333', 'https://openalex.org/W2106584820', 'https://openalex.org/W2117333061', 'https://openalex.org/W2118771330', 'https://openalex.org/W2127851369', 'https://openalex.org/W2129510594', 'https://openalex.org/W2131593570', 'https://openalex.org/W2140713688', 'https://openalex.org/W2160293821', 'https://openalex.org/W2163996018', 'https://openalex.org/W2168473428', 'https://openalex.org/W2169007954', 'https://openalex.org/W344535333', 'https://openalex.org/W46607909'], 'related_works': ['https://openalex.org/W4388673960', 'https://openalex.org/W4299347048', 'https://openalex.org/W4296621011', 'https://openalex.org/W4286817035', 'https://openalex.org/W2498520464', 'https://openalex.org/W2319910057', 'https://openalex.org/W2316427340', 'https://openalex.org/W2189342016', 'https://openalex.org/W2167485228', 'https://openalex.org/W2065576507'], 'abstract_inverted_index': {'The': [0], 'introduction': [1], 'of': [2, 17, 45], 'the': [3, 15, 42], 'hypomethylating': [4], 'agents': [5], 'azacitidine': [6, 48], 'and': [7, 26, 49], 'decitabine': [8], 'has': [9], 'been': [10], 'a': [11], 'major': [12], 'advancement': [13], 'in': [14], 'treatment': [16, 46], 'patients': [18], 'with': [19, 47], 'higher-risk': [20], 'myelodysplastic': [21], 'syndromes,': [22], 'chronic': [23], 'myelomonocytic': [24], 'leukemia,': [25], 'acute': [27], 'myeloid': [28], 'leukemia': [29], 'who': [30], 'are': [31], 'ineligible': [32], 'for': [33], 'more': [34], 'intensive': [35], 'treatments.': [36], 'This': [37], 'concise': [38], 'drug': [39], 'review': [40], 'summarizes': [41], 'current': [43], 'state': [44], 'decitabine.': [50]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2127289529', 'counts_by_year': [{'year': 2024, 'cited_by_count': 22}, {'year': 2023, 'cited_by_count': 29}, {'year': 2022, 'cited_by_count': 31}, {'year': 2021, 'cited_by_count': 21}, {'year': 2020, 'cited_by_count': 27}, {'year': 2019, 'cited_by_count': 24}, {'year': 2018, 'cited_by_count': 29}, {'year': 2017, 'cited_by_count': 17}, {'year': 2016, 'cited_by_count': 14}, {'year': 2015, 'cited_by_count': 19}, {'year': 2014, 'cited_by_count': 8}, {'year': 2013, 'cited_by_count': 4}], 'updated_date': '2024-12-12T12:23:29.114667', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
